Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in ...

Obesity causes various chronic diseases and conditions, including type 2 diabetes ... supply. Novo Nordisk hasn't been able to add manufacturing capacity fast enough. The U.S. Food and Drug ...

Novo Nordisk Warns Consumers About Counterfeit Versions of Ozempic in US (Reuters) - Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic ...

As the ultra-processed food (UPF) conversation continues ... The project was backed by the Novo Nordisk Foundation, the controlling shareholder of the big pharma business famous for making diabetes ...

Earlier in 2025, the U.S. Food and Drug Administration (FDA ... Richard Pratley, MD is a paid Novo Nordisk, Inc. spokesperson. Only Novo Nordisk manufactures FDA-approved semaglutide medicines, ...

The study evaluated the once-weekly injectable Ozempic (semaglutide 1.0 mg) in adults with type 2 diabetes ... Food and Drug Administration (FDA). A decision is anticipated in 2025. Novo Nordisk ...

March 28 (Reuters) - Novo Nordisk ... after its diabetes drug faced multiple setbacks. The company also said it would reduce its workforce by about 60%, after the U.S. Food and Drug Administration ...

Novo Nordisk says an oral drug which can help type 2 diabetes patients to lower their ... version must be taken on an empty stomach, with no food to be ingested for 30 minutes or otherwise its ...